A six-month follow-up study to evaluate changes of pulmonary function test in Category I pulmonary tuberculosis treatment completed patient
Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2018, Vol 8, Issue 1
Abstract
31National Journal of Physiology, Pharmacy and Pharmacology 2018 | Vol 8 | Issue 1RESEARCH ARTICLEA six-month follow-up study to evaluate changes of pulmonary function test in Category I pulmonary tuberculosis treatment completed patientPrashant J Patil, Sarika P PatilDepartment of Physiology, Shri Bhausaheb Hire Government Medical College, Dhule, Maharashtra, IndiaCorresponding to: Sarika P Patil, E-mail: durgapjp@gmail.comReceived: June 25, 2017; Accepted: July 21, 2017ABSTRACTBackground: Tuberculosis (TB) is being a preventable and curable disease that it accounts the world-wide problem. India is one of the TB burden countries. Clinical manifestation of pulmonary TB leads pulmonary dysfunction with functional changes in the lung tissue. Treated patients are free from mycobacterium and considered cured, but the restoration of lungs function in these patients is also needed. Aims and Objectives: This study plans to evaluate and compare the pulmonary function test (PFT) parameters immediately, 3 months and 6 months after the completion of TB treatment and assess its severity. Materials and Methods: By convenient sampling, 118 voluntarily participated pulmonary TB-treated patients completing Category I regimen. PFT during three intervals after the completion of full course of antitubercular drugs was evaluated. Spirometry was done in sitting position according to the American Thoracic Society (ATS) recommendation and interpretation of the results was done. Results: Male-to-female proportion of the pulmonary TB patients was 56.8% versus 43.2%, respectively, within 22-65 years. Maximum patients, that is, 39% were within 31-40-year-age group. Immediate after completion of the treatment, 7.6% had symptoms of exertion dyspnea which were not on follow-up visits. The percent predictive values of the PFT were marginally above the impairment values. There was statistically significant difference mean forced vital capacity (FVC) (P < 0.001), forced expiratory volume at one second/FVC ratio percentage (P < 0.01), peak expiratory flow rate (P < 0.05), and maximal voluntary ventilation (P < 0.01) at the three intervals. Pulmonary function results were normal in 89.8% of patients immediately after the completion of TB treatment, in 91.5% at 3 months and 88.1% at 6 months. Impaired pulmonary function values were in 10.2% of patients at immediate, 8.5% at 3 months, and 11.9% patients at 6 months after completion of TB treatment. The 6-month PFT findings in 6.8% had obstructive changes, 3.4% had restrictive, and 1.7% with mixed PFT changes. Conclusion: There is the presence of pulmonary functional limitations in Category I TB-treated patients. Values for PFT were still lower in few patients even after completion of 6 months of treatment for Category I pulmonary TB.
Authors and Affiliations
Prashant J Patil, Sarika P Patil
Keywords
Related Articles
- EP ID EP449658
- DOI 10.5455/njppp.2018.8.0724121072017
- Views 48
- Downloads 0
Effects of subchronic exposure of PSP Ganoderma lucidum on renal function and histopathology feature in Rattus novergicus Wistar strain
Background: Ganoderma lucidum, commonly referred to as Lingzhi in China, is a fungus that has been widely used through the centuries for the general promotion of health and longevity in Asian countries. Aims and O...
Study of visual evoked potentials in patients with type 2 diabetes mellitus and diabetic retinopathy
Background: Type 2 diabetes mellitus (T2DM) is a metabolic disorder showing an increasing trend with an increase in complications such as diabetic retinopathy (DR), which can cause blindness. Most patients do not notice...
Analysis of completeness of drug package inserts available in India
Background: Information about the drug used can be obtained from various sources of drug information. One of the easily available sources of drug information is package insert (PI). The PI is the primary source of drug i...
A comparative study of the variation in coagulation profile between different blood groups in ischemic heart disease patients and normal subjects
Background: A positive association of coagulation factors has been implicated with the risk of ischemic heart disease (IHD), and so have the associations of the ABO blood groups. Aims and Objectives: This study was done...
The ocular hypotensive effect of pregnancy
Background: Blindness ranked third (after cancer and heart disease) as people’s major fear. Glaucoma is the second leading cause of blindness in the world, according to the World Health Organization. Everyone is at risk...